The expression of several miRNAs in melanoma is altered by BRAFi and MEKi treatment [41,49,50] and reprogramming of miRNA expression is involved in the emergence of drug resistance in BRAF mutated melanoma [51]. This evidence concerns the gene BRAF and melanoma.